Patent · US Active

Heterocyclic antiestrogens

US11465990B2 · kind B2 · utility

0Cited by

6References

11Claims

0Family size

Assignee

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. · IN

Inventors

Ranjan Kumar Pal · Salumbar, IN
Amit Pravinbhai Sedani · Baroda, IN
Kaushikkumar Dhanjibhai Prajapati · Salumbar, IN
Dijixa Pinakin Rana · Salumbar, IN
Sandeep Pankajbhai Pathak · Felton, GB
Japan Nitinkumar Desai · Vadodara, IN
Jayraj Dilipbhai Aradhye · Salumbar, IN
Bhavesh Mohanbhai Panchal · Nagar, IN
Indraneel Ghosh · Salumbar, IN
Trinadha Rao Chitturi · Salumbar, IN

Key dates

Filing date	Oct 28, 2020
Grant date	Oct 11, 2022
Priority date	—
Expiry date	Oct 28, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D335/06
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides novel heterocyclic compounds as anticancer agents, especially as estrogen receptor (ER) antagonists/degraders and process for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.